GRECO, ELIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.383
EU - Europa 1.193
AS - Asia 1.171
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 4
SA - Sud America 4
Totale 10.770
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.369
CN - Cina 714
FI - Finlandia 317
SG - Singapore 283
IT - Italia 238
SE - Svezia 203
DE - Germania 157
UA - Ucraina 148
VN - Vietnam 95
GB - Regno Unito 56
KR - Corea 23
IN - India 21
RU - Federazione Russa 16
EU - Europa 15
NL - Olanda 14
IE - Irlanda 13
CA - Canada 12
FR - Francia 11
IR - Iran 8
JP - Giappone 8
RO - Romania 7
SI - Slovenia 6
TR - Turchia 4
TW - Taiwan 4
HK - Hong Kong 3
ID - Indonesia 3
IQ - Iraq 3
AU - Australia 2
BE - Belgio 2
ES - Italia 2
GR - Grecia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
KW - Kuwait 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 10.770
Salva come PNG Salva come JPEG
Città #
Ann Arbor 937
Woodbridge 891
Chandler 863
Houston 754
Fairfield 743
Jacksonville 711
Ashburn 543
Wilmington 422
Cambridge 329
Seattle 265
Princeton 230
Singapore 210
Des Moines 187
Medford 173
Beijing 169
Nanjing 148
Helsinki 118
Roxbury 102
Dong Ket 94
Boardman 91
San Diego 68
Guangzhou 49
Nanchang 48
Santa Clara 37
Shenyang 36
New York 35
Hebei 33
Jiaxing 32
Changsha 28
Padova 27
Tianjin 25
Jinan 22
Gangdong-gu 19
Los Angeles 16
Norwalk 16
Shanghai 15
Zhengzhou 15
London 14
Redwood City 13
Rome 13
Dublin 12
Bologna 10
Falls Church 10
Washington 10
Haikou 9
Taizhou 9
Dallas 8
Lanzhou 8
Milan 8
Naples 8
Pune 8
Turin 8
Borås 7
Florence 7
Kharkiv 7
Kunming 7
Munich 7
Cagliari 6
Indiana 6
Rockville 6
Tappahannock 6
Vicenza 6
Fuzhou 5
Hefei 5
Montreal 5
Ningbo 5
Ogden 5
Amsterdam 4
Bucharest 4
Genoa 4
Hangzhou 4
Lappeenranta 4
Poggiomarino 4
Redmond 4
Augusta 3
Detroit 3
Kilburn 3
Malo 3
Mestre 3
Nürnberg 3
Okazaki 3
Palermo 3
Renon 3
Yenibosna 3
Atlanta 2
Bari 2
Bassano del Grappa 2
Brescia 2
Campobasso 2
Chengdu 2
Chicago 2
Gallio 2
Geislingen an der Steige 2
Ghent 2
Guadalajara 2
Hamburg 2
Hong Kong 2
Lecce 2
Legnago 2
Lima 2
Totale 8.829
Salva come PNG Salva come JPEG
Nome #
Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success. 173
TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children. 142
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry 137
La mutazione S59P del gene TNFRSF1A, associata alla TRAPS, causa l'attivazione costitutiva della via del segnale NFkB 126
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. 125
The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway. 122
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications 121
New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis. sensitive two-test based strategy for celiac disease diagnosis. 121
Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 114
Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals 110
Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. 109
Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study. 106
Serum antibodies anti-H. pylori and anti CagA: a comparison between four different assays. 104
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. 103
Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides 102
Altered Intracellular Calcium Fluxes in Pancreatic Cancer Induced Diabetes Mellitus: Relevance of the S100A8 N-Terminal Peptide (NT-S100A8) 100
CD44v10: an antimetastatic membrane glycoprotein for pancreatic cancer 100
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 99
Helicobacter pylori infection in children and adults: a single pathogen but different pathology 99
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 98
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 96
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 96
Hyperglycemia-induced S100A8 and S100A9 expression target AKT, mTOR and NF-kB signalling in pancreatic cancer cells 95
Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy. 95
Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model 94
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 92
Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer 92
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 87
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 86
Pancreatic cancer gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary results. 82
Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children. 82
MMP9 and S100A9 expression in peripheral blood mononuclear cells (PBMC) are correlated with PDAC and with PDAC-associated diabetes mellitus. 82
Metastatic colo-rectal cancer cells stimulate collagen production by fibroblasts. 81
AESKULISA and H-TTG/DGP screen for celiac disease diagnosis. 81
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome 81
Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. 79
Helicobacter pylori virulence genes and host IL-1RN and IL-1b genes interplay in favoring the development of peptic ulcer and intestinal metaplasia 78
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. 78
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]i) ,oscillations and insulin release. 74
Pancreatic cancer (PC) gene therapy with heat inducible diphtheria toxin variant CRM197 (DTA197): in vivo preliminary data. 73
SMAD-4 RELATED AND UNRELATED SOLUBLE FACTORS AND EXOSOMES CO-OPERATE IN DETERMINING PDAC IMMUNOEVASION 73
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblast: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle gene 72
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 72
The inflammatory calcium binding protein S100A8 and its N-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-B1) and alter AKT, mTOR and NF-kB cancer cell signalling 72
Helicobacter Pylori EPIYA-C motifs are main determinants of intestinal metaplasia and gastric mucosa atrophy. 71
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 71
Hypergycemia-induced S100A8 and S100A9 expression target AKT, MTor and N-KB signalling in pancreatic cancer cells. 71
Gene therapy with HSV-TK: A promising tool for pancreatic cancer treatment? 70
Serum biomarkers of pancreatic cancer (PC) and pancreatic cancer derived diabetes mellitus (DM). 69
Pancreatic cancer associated diabetogeni peptide induces nitric oxide synthesis in rat hepathocytes 68
NT-S100A8 effects on cell signalling. 68
Expression profile of pancreatic cancer cell conditioned myoblast: a 5000 muscle genes microarray analysis 68
Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4. 68
Carcinogenetic potential of the WSR cagA region. 67
KLK3 and steroid 5-alpha reductase type II (SRD5A2) gene polymorphisms might affect clinical reliability of serum PSA measurement. 66
Suicide gene therapy with the yeast fusion gene Cytosine Deaminase/Uracil Phosphoribosyltransferase is not enough for pancreatic cancer 66
MALDI-TOF/MS biomarkers discovery for pancreatic cancer diagnosis: emerging role of apolipoprotein A1 and complement C3 66
A new laboratory friendly platform to detect the celiac disease associated HLA-DQ2 and DQ8 haplotype. 66
Retrovirus-mediated herpes simplex virus thymidine kinase gene transfer in pancreatic cancer cell lines: an incomplete antitumor effect 66
Predisposizione al cancro del pancreas: ruolo dei polimorfismi dei geni XRCC1, XRCC3 e CYP1A1 65
Gastropanel: a useful screening test in paediatric populations 65
Interferon gamma (IFNg) and interleukin-10 (IL-10) Haplotypes differently influence Helicobacter pylori infection outcome 65
A new indirect chemiluminescent immunoassay to measure anti-transglutaminase antibodies: more than a promise 64
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 64
Smad-4 related and unrelated soluble factors and exosomes cooperate in determining PDAC immunoevasion 64
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 63
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS 63
The pancreatic cancer derived N-terminal peptide of S100A8 stimulates insulin exocytosis and HEPG2 cell growth. 62
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 61
Celiac disease diagnosis and monitoring; comparison between chemiluminescence and ELISA anti-transglutaminase and anti-deamidated gliadin peptides measurements. 61
Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements 61
Urine protein profiling by maldi-tof/ms: normalization and reproducibility. 61
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 60
The pancreatic cancer (PC) derived S100A8 N-terminal peptide (NT-S100A8) augments intracellular Ca2+ ([Ca2+]) oscillations and insulin release. 60
The pancreatic cancer derived S100A8 N-terminal peptide augments intracellular Ca2+ oscillations and insulin release. 59
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 59
Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications. 59
Analogues of vitamin E epitomised by alpha-tochopherol succinate (alpha-TOS) for pancreatic cancer treatment: in vitro results induce caution for in vivo applications 58
K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA. 58
Engineering diphteria toxin in pancreatic cancer cells: a promising tool for therapy. 57
Gene therapy with HSV-TK: a promising tool for pancreatic cancer treatment? 57
Clinical relevance of circulating and splenic immature myeloid cells in pancreatic diseases. 57
Pancreatic cancer biomarkers discovery by SELDI-TOF-MS. 56
Analogues of vitamin E epitomized by alpha-tocopherol succinate (alpha-tos) for pancreatic cancer treatment: in vitro results induce caution for in vivo application. 56
TUMOR NECROSIS FACTOR ALPHA (TNF) PROMOTER HAPLOTYPE CONCURS WITH HLADQA1- DQB1 IN DETERMINING CELIAC DISEASE RISK 55
VKORC1 and CYP2C9 pharmacogenetics: relevance in warfarin maintenance dosing prediction. 54
Profilo di espressione di mioblasti condizionati da cellule di cancro del pancreas: analisi mediante microarray di 5000 geni muscolari 54
Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1 54
Isolation and characterization of pancreatic cancer (PC) diabetogenic factor: a 14 aminoacids peptide corresponding to the N-terminal sequence of an S-100 calcium binding protein 53
The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling 53
Identification of new IL12A and IL12B genes polymorphisms as host genetic factors interplaying with H. pylori 52
Carcinogenetic potential of the WSR cagA region of Helicobacter pylori. 52
NT-S100A8 inhibits insulin release and activates AKT and NF_KB cell signalling in pancreatic cancer (PC) cells. 52
Polimorfismi del gene TNFa : effetto sulla prognosi e l`esito del cancro del pancreas (CP)Polimorfismi del gene TNFa : effetto sulla prognosi e l`esito del cancro del pancreas (CP) 51
Pancreatic cancer (PC)-derived soluble mediators induce dendritic cells (DCs) to aquire an immunesuppressive phenotype by downregulating CTLA4. 51
Hypo and hyper-glycemia: inflammatory stimuli for circulating monocytes. 51
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 51
Transforming growth factor-beta 1 (TGF-B1) stimulation of pancreatic cancer cells evokes a different invasion pattern in vitro 50
Pancreatic cancer gene therapy with diphteria toxin A (DTA) and its variants CRM176 and CRM197. 50
Carcinogenetic potential of the WSR CagA region of Helicobacter pylori 49
Totale 7.672
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.871
article - articoli 10.755
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.390 0 0 40 106 144 132 103 194 151 281 146 93
2020/20211.277 63 108 54 161 65 100 14 116 171 89 172 164
2021/20221.462 19 353 77 50 49 108 33 92 72 14 153 442
2022/20231.939 379 211 25 206 339 302 9 110 232 19 71 36
2023/20241.006 36 121 105 73 67 166 70 87 23 56 88 114
2024/2025232 23 207 2 0 0 0 0 0 0 0 0 0
Totale 10.811